Doctor Dana Roxana Bataiosu
University Hospital Zurich, Zurich (Switzerland)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/5000x1496/8aa45c8224/eacvi-acronym-text-rgb.png)
Outcomes in patients with hypertrophic cardiomyopathy developing left ventricular systolic dysfunction after septal reduction therapy
Event: ESC Congress 2023
Topic: Hypertrophic Cardiomyopathy
Session: Contemporary management of hypertrophic cardiomyopathy
Left atrial remodelling after septal myectomy is associated with a reduced 5-year risk of atrial fibrillation in hypertrophic cardiomyopathy
Event: ESC Congress 2022
Topic: Hypertrophic Cardiomyopathy
Session: The genetic spectrum of hypertrophic cardiomyopathy
ESC 365 is supported by
